Quality of life among alcohol-dependent patients: how satisfactory are the available instruments? A systematic review.

[1]  M Salaspuro,et al.  A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence. , 2013, Alcohol and alcoholism.

[2]  D. Ciraulo,et al.  A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. , 2012, Alcoholism, clinical and experimental research.

[3]  D. Ciraulo,et al.  A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. , 2012, Alcoholism, clinical and experimental research.

[4]  A. Copello,et al.  Assertive Community Treatment for alcohol dependence (ACTAD): study protocol for a randomised controlled trial , 2012, Trials.

[5]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[6]  H. Aubin,et al.  Is controlled drinking an acceptable goal in the treatment of alcohol dependence? A survey of French alcohol specialists. , 2011, Alcohol and alcoholism.

[7]  R. Kolamunnage-Dona,et al.  A randomised controlled trial of extended brief intervention for alcohol dependent patients in an acute hospital setting (ADPAC) , 2011, BMC public health.

[8]  W. Zywiak,et al.  Beyond the Ubiquitous Relapse Curve: A Data-Informed Approach , 2011, Front. Psychiatry.

[9]  J. Bobes,et al.  Topiramate for the Treatment of Alcohol Dependence: Comparison with Naltrexone , 2010, European Addiction Research.

[10]  J. Calabrese,et al.  A double-blind, placebo-controlled study with quetiapine as adjunct therapy with lithium or divalproex in bipolar I patients with coexisting alcohol dependence. , 2010, Alcoholism, clinical and experimental research.

[11]  M. Ferraz,et al.  Cost-Effectiveness of Home Visits in the Outpatient Treatment of Patients with Alcohol Dependence , 2009, European Addiction Research.

[12]  W. Miller,et al.  What should we be aiming for in the treatment of addiction? , 2009, Addiction.

[13]  C. Zubaran,et al.  Quality of life and substance use: concepts and recent tendencies , 2009, Current opinion in psychiatry.

[14]  A. Zweben,et al.  Alcohol treatment effects on secondary nondrinking outcomes and quality of life: the COMBINE study. , 2009, Journal of studies on alcohol and drugs.

[15]  H. Kranzler,et al.  Effect of extended-release naltrexone (XR-NTX) on quality of life in alcohol-dependent patients. , 2009, Alcoholism, clinical and experimental research.

[16]  P. Aguiar,et al.  Effectiveness of sequential combined treatment in comparison with treatment as usual in preventing relapse in alcohol dependence. , 2008, Alcohol and alcoholism.

[17]  J. Bobes,et al.  Using topiramate or naltrexone for the treatment of alcohol-dependent patients. , 2008, Alcoholism, clinical and experimental research.

[18]  G. Bonsel,et al.  Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods , 2008, Quality of Life Research.

[19]  J. Lönnqvist,et al.  Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. , 2008, The Journal of clinical psychiatry.

[20]  S. Sareen,et al.  Yoga: a tool for improving the quality of life in chronic pancreatitis. , 2007, World journal of gastroenterology.

[21]  M. Angermeyer,et al.  The EQ-5D in alcohol dependent patients: relationships among health-related quality of life, psychopathology and social functioning. , 2007, Drug and alcohol dependence.

[22]  F. Bamfi,et al.  The FDA guidance for industry on PROs: the point of view of a pharmaceutical company , 2006, Health and quality of life outcomes.

[23]  P. Llorca,et al.  AlQoL 9 for measuring quality of life in alcohol dependence. , 2006, Alcohol and alcoholism.

[24]  A. Zweben,et al.  Quality of life as an outcome measure in alcoholism treatment research. , 2005, Journal of studies on alcohol. Supplement.

[25]  J. Endicott,et al.  Quality-of-life impairment in depressive and anxiety disorders. , 2005, The American journal of psychiatry.

[26]  P. Lehert,et al.  A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care. , 2004, Alcohol and alcoholism.

[27]  Jennie Z. Ma,et al.  Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. , 2004, Archives of general psychiatry.

[28]  T. Díez,et al.  Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: a randomized controlled trial. , 2003, Alcohol and alcoholism.

[29]  John P. Allen.  Measuring outcome in interventions for alcohol dependence and problem drinking: executive summary of a conference sponsored by the national institute on alcohol abuse and alcoholism. , 2003, Alcoholism, clinical and experimental research.

[30]  John E. Ware,et al.  SF-36 Health Survey Update , 2000, Spine.

[31]  M. Willenbring,et al.  A randomized trial of integrated outpatient treatment for medically ill alcoholic men. , 1999, Archives of internal medicine.

[32]  A. Zweben,et al.  Development of a composite measure for assessing alcohol treatment outcome: operationalization and validation. , 1999, Alcoholism, clinical and experimental research.

[33]  B. Burnand,et al.  MOS-SF-36 in evaluating health-related quality of life in alcohol-dependent patients. , 1998, The American journal of drug and alcohol abuse.

[34]  J. Ware,et al.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. , 1996, Medical care.

[35]  D. Drummond,et al.  The Alcohol Problems Questionnaire: reliability and validity. , 1994, Drug and alcohol dependence.

[36]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[37]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[38]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[39]  D. Drummond.  The relationship between alcohol dependence and alcohol-related problems in a clinical population. , 1990, British journal of addiction.

[40]  J. Cutler,et al.  Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS). , 1987, The American journal of cardiology.

[41]  E. C. Huskisson,et al.  Graphic representation of pain , 1976, Pain.

[42]  Harold D. Holder,et al.  Alcohol: no ordinary commodity--a summary of the second edition. , 2010, Addiction.

[43]  M. Angermeyer,et al.  Responsiveness of EQ-5D utility indices in alcohol-dependent patients. , 2008, Drug and alcohol dependence.

[44]  A. Leplège.  Les mesures de la qualité de vie , 1999 .

[45]  B. Ritson,et al.  THE SECCAT SURVEY: II. THE ALCOHOL RELATED PROBLEIN QUESTIONNAIRE AS A PROXY FOR RESOURCE COSTS AND QUA OF LIFE IN ALCOHOLISM TREATMENT , 1997 .

[46]  P. Viens,et al.  Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. , 1997, British Journal of Cancer.

[47]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[48]  J. Endicott,et al.  Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. , 1993, Psychopharmacology bulletin.

[49]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[50]  Alison J. Carr,et al.  An Ethical Dilemma Medical Errors and Medical Culture an Error of Omission Education and Debate , 2022 .